GG Ventures

Contacts: Skipped - triage

Description

GG Ventures - Investing in The Female Performance Stack A $1T+ opportunity unfolding at the intersection of health, sports, and longevity - reimagined through a female lens. We’re not indexing the category, we’re defining it. GG Ventures is Europe’s first and only investment platform focused on female performance. Investing since 2021, we’re now raising a $100M institutional Fund II to back AI-native, science-led companies reengineering the female health stack from the ground up. We invest at the inflection point—between Seed and Series A, where founder–market fit, data moats, and machine learning DNA converge to create exponential, compounding value. We partner with founders of any gender building from first principles, with AI as the engine. We back AI-native companies with proprietary data flywheels, predictive architectures that improve autonomously with every use, regulatory-grade infrastructure aligned with payers and globally compliant from day one, and defensible, scalable IP. Where we play: 1. Sports, Strength & Wellness 2. Next Gen Reproductivity 3. Longevity & Chronic Diseases 4. 7 Female Cancers 5. Mental Health / HealthTech Products & Services We leverage elite women’s sport as a high-velocity distribution engine—fueling access, adoption, and authenticity at scale. This isn’t niche. This is foundational to global health, economic resilience, and generational continuity. We’re not just backing the future of female performance, we’re engineering it.

Location

London, England, United Kingdom

Industry

Venture Capital and Private Equity Principals

Investor Type

Private Equity

Target Sectors

Verticals

No verticals classified

Financials

Revenue

EBITDA

Employees

15

Founded

2021

Classify Status

Triage: pure_vc — VC platform backing female performance startups

Prospects

0 people

No prospects linked to this account.

Outreach History

Outreach sequencing tables are not yet in Supabase.

ID: 13713Airtable: vayne-100577-294Created: 10/06/2026